Depressive Disorders - Pakistan | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$65.99m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.75%, resulting in a market volume of US$68.51m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$5.02 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Pakistan is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In Pakistan, there is a growing awareness and acceptance of mental health issues, including depressive disorders. This has led to an increased demand for treatment options and therapies for individuals suffering from depression. Customers are seeking accessible and affordable solutions to manage their mental health, leading to a rise in the demand for medications and therapy services.

Trends in the market: One of the key trends in the Depressive Disorders market in Pakistan is the increasing availability and accessibility of mental health services. Healthcare providers are expanding their offerings to include specialized mental health clinics and telemedicine services, making it easier for individuals to seek help for their depressive disorders. This trend is driven by the recognition of the impact of mental health on overall well-being and the need for comprehensive healthcare services.Another trend in the market is the adoption of evidence-based treatment approaches. Healthcare professionals are increasingly relying on research and clinical guidelines to inform their treatment decisions, resulting in more effective and targeted interventions for depressive disorders. This trend is driven by the desire to improve patient outcomes and optimize the use of healthcare resources.

Local special circumstances: Pakistan has a large population, with a significant portion of the population experiencing mental health issues, including depressive disorders. The country also faces challenges in terms of limited mental health infrastructure and resources. These local special circumstances have created a demand for innovative solutions and interventions to address the needs of the population. As a result, there is a growing focus on community-based mental health initiatives, such as support groups and awareness campaigns, to reach a wider audience and provide accessible care.

Underlying macroeconomic factors: The economic development and urbanization in Pakistan have contributed to the growth of the Depressive Disorders market. As the country undergoes rapid urbanization, individuals are facing increased stress and pressure, leading to a higher prevalence of depressive disorders. Additionally, the growing middle class in Pakistan has more disposable income, enabling them to access private healthcare services and invest in their mental well-being.In conclusion, the Depressive Disorders market in Pakistan is experiencing growth due to customer preferences for accessible and affordable mental health solutions, trends in the market towards increased availability of mental health services and evidence-based treatment approaches, local special circumstances that require innovative solutions, and underlying macroeconomic factors such as economic development and urbanization. This growth presents opportunities for healthcare providers and stakeholders to further invest in the Depressive Disorders market and improve the mental well-being of the population.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.